Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study
about
The heart failure revascularisation trial (HEART): rationale, design and methodology.Demographics, treatment regimens and the use of angiotensin-receptor blockers in heart failure: findings from the Valsartan Heart Failure Trial.Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.Fish oils--adjuvant therapy in chronic heart failure?Lipid-lowering therapy and outcomes in heart failure.Carvedilol in the treatment of elderly patients with chronic heart failure.Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure.Role of antithrombotic agents in heart failure.How robust are clinical trials in heart failure?Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy.Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: role of myocardial viability.
P2860
Q35150706-00A5FB60-6315-4409-9C4C-2C3CE3D0DF3AQ35572277-252EF1BC-FAAD-4C0D-B119-4E8DB8F314BDQ35849384-8F6F087A-6562-4F8A-B01E-BEED7F9BED11Q35855345-8F52965D-8BC0-4C7A-B155-EF96F8DBEBA3Q36818242-19BD9909-7082-413E-976C-5A5A53F5B95AQ36892905-D9A8E368-FA4D-4EEF-9429-C57121D8E7F6Q37122888-EF9A5841-948B-44A7-ADDB-0994D2C3739AQ37998952-ED099A86-4602-4331-BF15-6907E8D42FF8Q39289642-D258BC3A-83B6-4839-882B-BC216C9454C5Q41255054-EE927CBB-2948-4DC9-B5E2-6A242A6A16A4Q43754539-8524AB7D-407A-4592-8F92-86C5EBE216DBQ45912425-98ED540C-DAB7-4EA3-96E5-C4C617264C21Q46635614-58A921F3-6B1F-4866-81E9-23E5D5826AB8Q46722055-A2DE8219-5202-4E5E-AA3F-ACCA2A24492C
P2860
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study
description
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2001
@uk
name
Cardiovascular critical event ...... a report from the ATLAS study
@en
Cardiovascular critical event ...... a report from the ATLAS study
@nl
type
label
Cardiovascular critical event ...... a report from the ATLAS study
@en
Cardiovascular critical event ...... a report from the ATLAS study
@nl
prefLabel
Cardiovascular critical event ...... a report from the ATLAS study
@en
Cardiovascular critical event ...... a report from the ATLAS study
@nl
P356
P1476
Cardiovascular critical event ...... a report from the ATLAS study
@en
P304
P356
10.1053/EUHJ.2000.2570
P50
P577
2001-09-01T00:00:00Z